Putting a price tag on novel autologous cellular therapies

Cell therapies, especially autologous therapies, pose significant challenges to researchers who wish to move from small, probably academic, methods of manufacture to full commercial scale. There is a dearth of reliable information about the costs of operation, and this makes it difficult to predict...

Full description

Bibliographic Details

Main Authors:	Mohamed Abou-El-Enein, Gerhard Bauer, Nick Medcalf, Hans-Dieter Volk, Petra Reinke
Format:	Default Article
Published:	2016
Subjects:	Mechanical engineering not elsewhere classified Adoptive T-cell therapy Commercialization Cost of goods Good manufacturing practice Immunotherapy Market adoption Price Regulation Reimbursement Scale-up Mechanical Engineering not elsewhere classified
Online Access:	https://hdl.handle.net/2134/21921
Tags:	Add Tag No Tags, Be the first to tag this record!